These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


705 related items for PubMed ID: 20955499

  • 1. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Venkatesh KK, Lurie MN, Triche EW, De Bruyn G, Harwell JI, McGarvey ST, Gray GE.
    Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
    [Abstract] [Full Text] [Related]

  • 2. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 3. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
    Morden E, Technau KG, Giddy J, Maxwell N, Keiser O, Davies MA.
    PLoS One; 2016 Jul; 11(4):e0151762. PubMed ID: 27049853
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal growth during the first 2 years of life in children born to HIV-infected mothers in Malawi, Africa.
    Henderson RA, Miotti PG, Saavedra JM, Dallabetta G, Chiphangwi J, Liomba G, Taha TE, Yolken RH.
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):91-7. PubMed ID: 11361486
    [Abstract] [Full Text] [Related]

  • 5. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 15; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 7. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, Zimba I, Ceffa S, Palombi L.
    Pediatr Infect Dis J; 2009 Jun 15; 28(6):483-7. PubMed ID: 19483516
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 9. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL.
    N Engl J Med; 1994 Nov 03; 331(18):1173-80. PubMed ID: 7935654
    [Abstract] [Full Text] [Related]

  • 10. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K.
    Pediatrics; 1995 Sep 03; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [Abstract] [Full Text] [Related]

  • 11. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.
    N Engl J Med; 1996 Nov 28; 335(22):1621-9. PubMed ID: 8965861
    [Abstract] [Full Text] [Related]

  • 12. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 13. Early growth of infants of HIV-infected and uninfected Zambian women.
    Makasa M, Kasonka L, Chisenga M, Sinkala M, Chintu C, Tomkins A, Filteau S.
    Trop Med Int Health; 2007 May 15; 12(5):594-602. PubMed ID: 17445127
    [Abstract] [Full Text] [Related]

  • 14. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
    Omer SB, Six Week Extended Dose Nevirapine (SWEN) Study Team.
    AIDS; 2011 Mar 27; 25(6):767-76. PubMed ID: 21330912
    [Abstract] [Full Text] [Related]

  • 15. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M.
    Pediatr Infect Dis J; 2006 Apr 27; 25(4):325-32. PubMed ID: 16567984
    [Abstract] [Full Text] [Related]

  • 16. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV, Brandt CD, Rakusan TA, Wientzen R, Fuccillo DA, Sever JL.
    Pediatr AIDS HIV Infect; 1996 Oct 27; 7(5):325-30. PubMed ID: 11361490
    [Abstract] [Full Text] [Related]

  • 17. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG, Pediatric Spectrum of HIV Disease Consortium.
    Pediatrics; 2007 Apr 27; 119(4):e900-6. PubMed ID: 17353299
    [Abstract] [Full Text] [Related]

  • 18. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK, NISDI Perinatal Study Group.
    Obstet Gynecol; 2007 Jun 27; 109(6):1358-67. PubMed ID: 17540808
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
    Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E.
    Bull World Health Organ; 2005 Jul 27; 83(7):489-94. PubMed ID: 16175822
    [Abstract] [Full Text] [Related]

  • 20. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.
    Powis KM, Smeaton L, Hughes MD, Tumbare EA, Souda S, Jao J, Wirth KE, Makhema J, Lockman S, Fawzi W, Essex M, Shapiro RL.
    AIDS; 2016 Jan 27; 30(2):211-20. PubMed ID: 26684818
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.